About Viatris, Inc. 
Viatris, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 123 Schemes (45.61%)
Foreign Institutions
Held by 383 Foreign Institutions (11.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3,705 Million
(Quarterly Results - Dec 2025)
Net Profit:
-340 Million
Pharmaceuticals & Biotechnology
USD 15,888 Million (Mid Cap)
NA (Loss Making)
NA
81.81%
0.88
-2.14%
1.04






